Supply Chain Intelligence

Disc Medicine, Inc. Supply Chain

IRON supply chain intelligence for Disc Medicine, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

IRON ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

4Suppliers
2Customers
3Debt Items
20Related Chains

Disc Medicine, Inc. Suppliers

TickerNameConfidenceEvidence
ABBV AbbVie Inc. 92% Under the AbbVie Agreement, we obtained an exclusive, worldwide license, with the right to sublicense to commercial pharmaceutical and biopharmaceutical companies under certain patents and technical …
ABBV AbbVie Inc. 92% Reciprocal relationship from ABBV graph: Reciprocal relationship from IRON graph: Reciprocal relationship from ABBV graph: Reciprocal relationship from IRON graph: Under the AbbVie Agreement, we obta…
ABBVIE-DEUTSCHLAND-GMBH-CO-KG ABBVIE-DEUTSCHLAND-GMBH-CO-KG 92% Under the license agreement with AbbVie, or the AbbVie Agreement, we obtained an exclusive, worldwide license, with the right to sublicense to commercial pharmaceutical and biopharmaceutical companie…
ROCHE ROCHE 92% Pursuant to the terms of the Roche Agreement and in connection with the Company's reverse merger with Gemini, the Company issued 482,313 shares of the Company to Roche for no consideration.

Disc Medicine, Inc. Customers

TickerNameConfidenceEvidence
GEMINI-THERAPEUTICS-INC GEMINI-THERAPEUTICS-INC 62% ering from hematologic diseases. The Company was founded in October 2017. The Company’s principal offices are located in Watertown, Massachusetts. The Company is subject to a number of risks and unce…
GEMSTONE-MERGER-SUB-INC GEMSTONE-MERGER-SUB-INC 62% ering from hematologic diseases. The Company was founded in October 2017. The Company’s principal offices are located in Watertown, Massachusetts. The Company is subject to a number of risks and unce…

Disc Medicine, Inc. Debt Obligations

InstrumentDescriptionConfidenceEvidence
IRON-DEBT-10364 Warrants outstanding: 5.46 90% xbrl warrant detail from xbrl 2020-12-31.
IRON-DEBT Debt stack $31.1M 90% Market cache reports total debt of $31.1M.
IRON-DEBT-10365 Xbrl Convertible 90% xbrl convertible detail from xbrl 2020-12-31.

Disc Medicine, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Disc Medicine, Inc..

Disc Medicine, Inc. Ownership

HolderNameConfidenceEvidence
IRON-OWNER-FMR-LLC FMR LLC 90% 13F overlay lists FMR LLC as top holder; 207 tracked holders.

Disc Medicine, Inc. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
MRK Merck & Co., Inc. 100.00 2
SNYNF Sanofi 100.00 2
ALT Altimmune, Inc. 100.00 2
MAZE Maze Therapeutics, Inc. 100.00 2
RCUS Arcus Biosciences, Inc. 100.00 2
REPL Replimune Group, Inc. 100.00 2
BCYC Bicycle Therapeutics plc 100.00 2
KPTI Karyopharm Therapeutics Inc. 100.00 2
ALEC Alector, Inc. 100.00 2
ABBV AbbVie Inc. 100.00 1 ['supplier']
CMPS COMPASS Pathways plc 100.00 2
ENGN enGene Therapeutics Inc. 100.00 2
DYN Dyne Therapeutics, Inc. 100.00 2
KURA Kura Oncology, Inc. 100.00 2
OBIO Orchestra BioMed Holdings, Inc. 100.00 2
MDGL Madrigal Pharmaceuticals, Inc. 100.00 2
PHGE BiomX Inc. 100.00 2
SGHT Sight Sciences, Inc. 100.00 2
NVSEF Novartis AG 100.00 2
VRDN Viridian Therapeutics, Inc. 100.00 2
View IRON supply chain intel →

Explore the full interactive supply chain map for Disc Medicine, Inc..

Open IRON supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map